CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to DSKYF

Ifinatamab deruxtecan (I-DXd)

Phase 2
Daiichi Sankyo (DSKYF)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q2 '27
DSKYFPhase 2

Ifinatamab deruxtecan (I-DXd) Phase 2 Est. Readout

Ifinatamab deruxtecan (I-DXd)
Q2 2027~Q
CT.gov
00%
Drug Information

Target Indication

Advanced Solid Tumor

Clinical Trial

NCT04145622

Last updated: 12/23/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.